ADLI American Medical Technologies Inc (CE)

American Medical Technologies, Inc. ("AMT" or the "Company") (OTCBB:ADLI) announced today that effective April 15, 2006, the company has entered into an exclusive sales distribution agreement with CoreStrength, Inc. whereby CoreStrength's sales force will distribute AMT's dental products to dental dealers throughout North America. Roger, W. Dartt, President and Chief Executive Officer of AMT stated, "We are very pleased to have this experienced team of dental sales professionals distributing our products to dental dealers throughout North America." AMT develops, manufactures and markets high-technology dental products utilizing a patented Hydrobrasion(TM) technique and recently acquired the exclusive worldwide distribution rights to the Spectrum Dental tooth whitening product line. AMT's hydrobrasion products are marketed under the brand names of HydroJet(TM) and supports the dental professional's requirement to provide the patient with a dramatic alternative to the conventional handpiece or standard anesthetic needle. The Spectrum tooth whitening products are marketed under the brand names of Contrastpm(TM), Contrastpm(TM)plus and Contrastam(TM). "We are excited with the opportunity to expand the HydroJet(TM) and Spectrum brands. Dental whitening products are used in most dental offices in North America. The Spectrum Dental line is an established brand that has a long history of partnering with dental dealers who help educate the dentist in the dental whitening process. The HydroJet(TM) is an exciting hydrobrasion product that is a unique alternative to the shot and drill process. CoreStrength's expertise is developing dealer partnering programs through their established field sales organization. AMT and CoreStrength is a good match," said Jeffrey Goodman, CEO of CoreStrength. AMT develops, manufactures and markets high-technology Hydrobrasion(TM) products designed primarily for general dentistry that are a dramatic alternative to the shot and drill. AMT's patented Hydrobrasion(TM) products provide dentists with a minimally invasive process that safely removes dental tooth structure and tooth decay by means of a slurry composed of air, water and micro particles. The Hydrobrasion(TM) technology and recently introduced HydroJet(TM) product line lessens patient sensitivity and may be used to treat a patient without anesthesia. The Company's securities are quoted on the OTC Bulletin Board under the symbol ADLI, and its website is at www.americanmedicaltech.com. The Company makes forward-looking statements in this press release and in its filings with the Securities and Exchange Commission. The Company's forward-looking statements are subject to risks and uncertainties and include information about its expectations and possible or assumed future results of operations. When the Company uses any of the words "believes," "expects," "anticipates," "estimates" or similar expressions, it is making forward-looking statements. To the extent available to it, the Company claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 for all of its forward-looking statements. While the Company believes that its forward-looking statements are reasonable, you should not place undue reliance on any such forward-looking statements, which speak only as of the date made. Because these forward-looking statements are based on estimates and assumptions that are subject to significant business, economic and competitive uncertainties, many of which are beyond the Company's control or are subject to change, actual results could be materially different. Factors that might cause such a difference include, without limitation, the following: the Company's inability to generate sufficient cash flow to meet its current liabilities, the Company's potential inability to hire and retain qualified sales and service personnel, the potential for an extended decline in sales, the possible failure of revenues to offset additional costs associated with its change in business model, the potential lack of product acceptance, the Company's potential inability to introduce new products to the market, the potential failure of customers to meet purchase commitments, the potential loss of customer relationships, the potential failure to receive or maintain necessary regulatory approvals, the extent to which competition may negatively affect prices and sales volumes or necessitate increased sales expenses, and the other risks and uncertainties. Other factors not currently anticipated by management may also materially and adversely affect the Company's results of operations. Except as required by applicable law, the Company does not undertake any obligation to publicly release any revisions which may be made to any forward-looking statements to reflect events or circumstances occurring after the date of this report.